Skip Navigation

Kit Check’s Diversion Trends Report Reveals 8% of Controlled Substance Transactions in Hospitals Had Discrepancies Indicative of Potential Drug Diversion

Blog

Kit Check’s Diversion Trends Report Reveals 8% of Controlled Substance Transactions in Hospitals Had Discrepancies Indicative of Potential Drug Diversion

Kit Check, the industry leader in Medication Intelligence™ solutions for hospitals, today announced the findings…

Blog

Kit Check Launches First Annual Medication Intelligence Summit to Unite Industry Leaders and Explore Hospital Pharmacy Operation Trends 

Virtual summit will bring together healthcare executives, experts, and pharmacists for panel discussions and informative…

Blog

Kit Check Hospital Pharmacy Operations Report Reveals For The Fourth Consecutive Year Drug Shortages are the #1 Challenge Facing Hospital Pharmacies. 

Report shows COVID-19 related issues such as drug shortages and staffing issues still remain a…

Blog

Kit Check Hires New Chief Financial Officer

Kit Check strengthens C-Suite with growth-oriented financial hire ALEXANDRIA, March 3rd, 2022- Kit Check, the…

Blog

Kit Check Passes SOC 2/3 Type 2 Examination for Security Compliance

Software healthcare company continues to strengthen commitment to security and trust   ALEXANDRIA- February 17th,…

Blog

Kit Check’s Bluesight® for Controlled Substances is Named Best in KLAS for the 3rd Consecutive Year

For the third year running, Bluesight for Controlled Substances takes top marks in all product…

Blog

Kit Check Launches Webinar Series Focused on RFID Innovation in Healthcare

Kit Check launches educational webinar series focused on supporting ASHP’s Enhancing Adoption of RFID Technology…

Blog

Kit Check and Fagron Partner to Launch RFID-tagged 503B Products in February 2022

503B Compounder Set to Manufacture Products Embedded with RFID tags Compatible with Kit Check Scanning…

Blog

Kit Check Hires New Chief Technology Officer

WASHINGTON, August 30 – Kit Check,  the leading automation vendor in Medication Intelligence™ today announced…

3 of 11